Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
2.
Aliment Pharmacol Ther ; 45(2): 364-372, 2017 01.
Artículo en Inglés | MEDLINE | ID: mdl-27885681

RESUMEN

BACKGROUND: Refractory coeliac disease, enteropathy associated T-cell lymphoma and small bowel adenocarcinoma are rare but prognostically important complications in coeliac disease. AIM: To analyse potential changes in occurrence of complicated coeliac disease over the last 25 years. METHODS: One thousand one hundred and thirty eight patients were included and evaluated based on their time of first presentation at the Medical University of Vienna, Austria. Occurrences of refractory coeliac disease and associated malignancies were evaluated for 5-year intervals from January 1990 until December 2014 and were compared over time. RESULTS: 2.6% (n = 29) were diagnosed with refractory coeliac disease (females 65.6%, mean age at diagnosis 62.8 years). The proportion of those patients was 2.6%, 3.1%, 3.3%, 2.7% and 0.5% for the 5 year intervals from 1990 onwards. Thus, the number of refractory cases has been decreasing since 2000 (P = 0.024). The number of patients presenting with lymphoma (n = 7) was 0.6%, 0.4%, 1.1%, 0.8% and 0% from 1990 to 2014. Similarly the number of patients with adenocarcinoma (n = 4) decreased to 0% until 2014. Overall mortality in patients suffering from refractory disease was 48%. Of all patients diagnosed with lymphoma 71.4% died with a 5-year survival rate of 28.6%. CONCLUSIONS: Over the past 15 years the occurrence of complicated coeliac disease has been decreasing. This possibly reflects a higher awareness of coeliac disease and optimised diagnosis and treatment with avoidance of long-term immunological disease activity. Symptomatic disease and a delay in diagnosis are risk factors for refractory coeliac disease and related cancer.


Asunto(s)
Adenocarcinoma/epidemiología , Enfermedad Celíaca/epidemiología , Neoplasias Intestinales/epidemiología , Linfoma de Células T/epidemiología , Adenocarcinoma/diagnóstico , Adenocarcinoma/etiología , Adulto , Anciano , Austria/epidemiología , Enfermedad Celíaca/complicaciones , Enfermedad Celíaca/diagnóstico , Femenino , Humanos , Neoplasias Intestinales/diagnóstico , Neoplasias Intestinales/etiología , Intestino Delgado/patología , Linfoma de Células T/diagnóstico , Linfoma de Células T/etiología , Masculino , Persona de Mediana Edad , Pronóstico , Factores de Riesgo , Tasa de Supervivencia
3.
J Cyst Fibros ; 14(4): 523-5, 2015 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-25866146

RESUMEN

We report on an adult patient with cystic fibrosis after double-lung transplantation under triple immunosuppression with non-specific abdominal symptoms and a pancreatic cystic tumor, resulting in the diagnosis of an intraductal papillary mucinous neoplasm (IPMN) of the pancreas. Pancreatic cysts in adult patients with cystic fibrosis, especially after transplantation, merit close attention and thorough investigation.


Asunto(s)
Carcinoma Ductal Pancreático/patología , Fibrosis Quística/patología , Fibrosis Quística/cirugía , Trasplante de Pulmón , Neoplasias Pancreáticas/patología , Carcinoma Ductal Pancreático/cirugía , Femenino , Humanos , Persona de Mediana Edad , Neoplasias Pancreáticas/cirugía
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA